Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel. The nucleotide-binding domain 1 (NBD1) is one of two cytosolic nucleotide-binding domains within CFTR that are essential for its function as an ATP-gated ion channel. Mutations affecting structure or function of CFTR, particularly those impacting folding or stability of NBD1 such as ΔF508, lead to cystic fibrosis due to defective chloride transport.
Modulation of NBD1 folding and stability to enhance CFTR function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cystic Fibrosis Transmembrane Conductance Regulator Nucleotide-Binding Domain 1 (CFTR NBD1).